Literature DB >> 18597733

Influence of Friedreich ataxia GAA noncoding repeat expansions on pre-mRNA processing.

Marco Baralle1, Tibor Pastor, Erica Bussani, Franco Pagani.   

Abstract

The intronic GAA repeat expansion in the frataxin (FXN) gene causes the hereditary neurodegenerative disorder Friedreich ataxia. Although it is generally believed that GAA repeats block transcription elongation, direct proof in eukaryotic systems is lacking. We tested in hybrid minigenes the effect of GAA and TTC repeats on nascent transcription and pre-mRNA processing. Unexpectedly, disease-causing GAA(100) repeats did not affect transcriptional elongation in a nuclear HeLa Run On assay, nor did they affect pre-mRNA transcript abundance. However, they did result in a complex defect in pre-mRNA processing. The insertion of GAA but not TTC repeats downstream of reporter exons resulted in their partial or complete exclusion from the mature mRNAs and in the generation of a variety of aberrant splicing products. This effect of GAA repeats was observed to be position and context dependent; their insertion at different distances from the reporter exons had a variable effect on splice-site selection. In addition, GAA repeats bind to a multitude of different splicing factors and induced the accumulation of an upstream pre-mRNA splicing intermediate, which is not turned over into mature mRNA. When embedded in the homologous frataxin minigene system, the GAA repeats did not affect the pre-mRNA transcript abundance but did significantly reduce the splicing efficiency of the first intron. These data indicate an association between GAA noncoding repeats and aberrant pre-mRNA processing because binding of transcribed GAA repeats to a multitude of trans-acting splicing factors can interfere with normal turnover of intronic RNA and thus lead to its degradation and a lower abundance of mature mRNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18597733      PMCID: PMC2443835          DOI: 10.1016/j.ajhg.2008.06.018

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  61 in total

1.  Inhibitory effects of expanded GAA.TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo.

Authors:  K Ohshima; L Montermini; R D Wells; M Pandolfo
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

2.  Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display.

Authors:  A F Muro; M Caputi; R Pariyarath; F Pagani; E Buratti; F E Baralle
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich's ataxia.

Authors:  N Sakamoto; P D Chastain; P Parniewski; K Ohshima; M Pandolfo; J D Griffith; R D Wells
Journal:  Mol Cell       Date:  1999-04       Impact factor: 17.970

4.  Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing.

Authors:  R Tacke; M Tohyama; S Ogawa; J L Manley
Journal:  Cell       Date:  1998-04-03       Impact factor: 41.582

5.  Replication-mediated instability of the GAA triplet repeat mutation in Friedreich ataxia.

Authors:  Laura M Pollard; Rajesh Sharma; Mariluz Gómez; Sonali Shah; Martin B Delatycki; Luigi Pianese; Antonella Monticelli; Bronya J B Keats; Sanjay I Bidichandani
Journal:  Nucleic Acids Res       Date:  2004-11-08       Impact factor: 16.971

6.  Novel modes of splicing repression by PTB.

Authors:  Rachel Spellman; Christopher W J Smith
Journal:  Trends Biochem Sci       Date:  2006-01-05       Impact factor: 13.807

7.  Expansion of GAA trinucleotide repeats in mammals.

Authors:  Rhonda M Clark; Sanjeev S Bhaskar; Masaki Miyahara; Gillian L Dalgliesh; Sanjay I Bidichandani
Journal:  Genomics       Date:  2005-11-28       Impact factor: 5.736

8.  Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation.

Authors:  Malka Nissim-Rafinia; Micha Aviram; Scott H Randell; Liat Shushi; Efrat Ozeri; Ornit Chiba-Falek; Ofer Eidelman; Harvey B Pollard; James R Yankaskas; Batsheva Kerem
Journal:  EMBO Rep       Date:  2004-11       Impact factor: 8.807

9.  GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases.

Authors:  A M Gacy; G M Goellner; C Spiro; X Chen; G Gupta; E M Bradbury; R B Dyer; M J Mikesell; J Z Yao; A J Johnson; A Richter; S B Melançon; C T McMurray
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

10.  Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer.

Authors:  P Cramer; J F Cáceres; D Cazalla; S Kadener; A F Muro; F E Baralle; A R Kornblihtt
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

View more
  26 in total

Review 1.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  Intron cleavage affects processing of alternatively spliced transcripts.

Authors:  Tibor Pastor; Andrea Dal Mas; Gabriele Talotti; Erica Bussani; Franco Pagani
Journal:  RNA       Date:  2011-06-14       Impact factor: 4.942

3.  Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs.

Authors:  D Wang; Y Guo; S A Wrighton; G E Cooke; W Sadee
Journal:  Pharmacogenomics J       Date:  2010-04-13       Impact factor: 3.550

Review 4.  Chromatin changes in the development and pathology of the Fragile X-associated disorders and Friedreich ataxia.

Authors:  Daman Kumari; Rachel Lokanga; Dmitry Yudkin; Xiao-Nan Zhao; Karen Usdin
Journal:  Biochim Biophys Acta       Date:  2012-01-05

5.  Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck.

Authors:  Hongxia Ma; Hongping Yu; Zhensheng Liu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Pharmacogenet Genomics       Date:  2012-01       Impact factor: 2.089

6.  MiRNA-145 Regulates the Development of Congenital Heart Disease Through Targeting FXN.

Authors:  Lei Wang; Danqiu Tian; Jihua Hu; Haijian Xing; Min Sun; Juanli Wang; Qiang Jian; Hua Yang
Journal:  Pediatr Cardiol       Date:  2015-12-30       Impact factor: 1.655

Review 7.  Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia.

Authors:  Joel M Gottesfeld; James R Rusche; Massimo Pandolfo
Journal:  J Neurochem       Date:  2013-08       Impact factor: 5.372

8.  Expression of human frataxin is regulated by transcription factors SRF and TFAP2.

Authors:  Kuanyu Li; Anamika Singh; Daniel R Crooks; Xiaoman Dai; Zhuangzhuang Cong; Liang Pan; Dung Ha; Tracey A Rouault
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

9.  Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck.

Authors:  Hongguang Guo; Hongliang Liu; Jianhua Wei; Yangkai Li; Hongping Yu; Xiaoxiang Guan; Wang Li-E; Guojun Li; Erich M Sturgis; Qingyi Wei; Zhensheng Liu
Journal:  Eur J Cancer       Date:  2013-11-29       Impact factor: 9.162

10.  Intron retention induced by microsatellite expansions as a disease biomarker.

Authors:  Łukasz J Sznajder; James D Thomas; Ellie M Carrell; Tammy Reid; Karen N McFarland; John D Cleary; Ruan Oliveira; Curtis A Nutter; Kirti Bhatt; Krzysztof Sobczak; Tetsuo Ashizawa; Charles A Thornton; Laura P W Ranum; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.